Jensen SM - Search Results

1

Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) Study.

Taube JM, Roman K, Engle EL, Wang C, Ballesteros-Merino C, Jensen SM, McGuire J, Jiang M, Coltharp C, Remeniuk B, Wistuba I, Locke D, Parra ER, Fox BA, Rimm DL, Hoyt C. Taube JM, et al. Among authors: jensen sm. J Immunother Cancer. 2021 Jul;9(7):e002197. doi: 10.1136/jitc-2020-002197. J Immunother Cancer. 2021. PMID: 34266881 Free PMC article.

2

Regression of a mammary adenocarcinoma in STAT6-/- mice is dependent on the presence of STAT6-reactive T cells.

Jensen SM, Meijer SL, Kurt RA, Urba WJ, Hu HM, Fox BA. Jensen SM, et al. J Immunol. 2003 Feb 15;170(4):2014-21. doi: 10.4049/jimmunol.170.4.2014. J Immunol. 2003. PMID: 12574371

3

Adoptive cellular immunotherapy of cancer: a three-signal paradigm for translating recent developments into improved treatment strategies.

Jensen SM, Fox BA. Jensen SM, et al. Cancer Treat Res. 2005;123:293-336. Cancer Treat Res. 2005. PMID: 16211876 Review. No abstract available.

4

Induction of circulating tumor-reactive CD8+ T cells after vaccination of melanoma patients with the gp100 209-2M peptide.

Meijer SL, Dols A, Jensen SM, Hu HM, Miller W, Walker E, Romero P, Fox BA, Urba WJ. Meijer SL, et al. Among authors: jensen sm. J Immunother. 2007 Jul-Aug;30(5):533-43. doi: 10.1097/CJI.0b013e3180335b5e. J Immunother. 2007. PMID: 17589294 Clinical Trial.

5

Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunity.

Petrausch U, Jensen SM, Twitty C, Poehlein CH, Haley DP, Walker EB, Fox BA. Petrausch U, et al. Among authors: jensen sm. J Immunol. 2009 Sep 15;183(6):3682-9. doi: 10.4049/jimmunol.0900560. Epub 2009 Aug 19. J Immunol. 2009. PMID: 19692636 Free PMC article.

6

Partial CD4 depletion reduces regulatory T cells induced by multiple vaccinations and restores therapeutic efficacy.

LaCelle MG, Jensen SM, Fox BA. LaCelle MG, et al. Among authors: jensen sm. Clin Cancer Res. 2009 Nov 15;15(22):6881-90. doi: 10.1158/1078-0432.CCR-09-1113. Epub 2009 Nov 10. Clin Cancer Res. 2009. PMID: 19903784 Free PMC article.

7

Tumor-derived autophagosome vaccine: induction of cross-protective immune responses against short-lived proteins through a p62-dependent mechanism.

Twitty CG, Jensen SM, Hu HM, Fox BA. Twitty CG, et al. Among authors: jensen sm. Clin Cancer Res. 2011 Oct 15;17(20):6467-81. doi: 10.1158/1078-0432.CCR-11-0812. Epub 2011 Aug 2. Clin Cancer Res. 2011. PMID: 21810919 Free PMC article.

8

Multiple vaccinations: friend or foe.

Church SE, Jensen SM, Twitty CG, Bahjat K, Hu HM, Urba WJ, Fox BA. Church SE, et al. Among authors: jensen sm. Cancer J. 2011 Sep-Oct;17(5):379-96. doi: 10.1097/PPO.0b013e3182346320. Cancer J. 2011. PMID: 21952289 Free PMC article. Review.

9

Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence.

Jensen SM, Twitty CG, Maston LD, Antony PA, Lim M, Hu HM, Petrausch U, Restifo NP, Fox BA. Jensen SM, et al. J Immunol. 2012 Jul 15;189(2):767-76. doi: 10.4049/jimmunol.1103822. Epub 2012 Jun 20. J Immunol. 2012. PMID: 22723522 Free PMC article.

10

Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells.

Church SE, Jensen SM, Antony PA, Restifo NP, Fox BA. Church SE, et al. Among authors: jensen sm. Eur J Immunol. 2014 Jan;44(1):69-79. doi: 10.1002/eji.201343718. Epub 2013 Nov 21. Eur J Immunol. 2014. PMID: 24114780 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233 results

Search Page

Filters